Zollinger‑Ellison-Associated Diarrhea - Symptoms, Causes, Treatment & Prevention

```html Zollinger‑Ellison‑Associated Diarrhea – Complete Medical Guide

Zollinger‑Ellison‑Associated Diarrhea: A Comprehensive Guide

Overview

Zollinger‑Ellison syndrome (ZES) is a rare, hormone‑producing tumor (gastrinoma) that originates in the pancreas or duodenum. The tumor releases excessive amounts of gastrin, a hormone that stimulates the stomach lining to produce large volumes of gastric acid. When the acid load overwhelms the small intestine’s protective mechanisms, patients often develop chronic, watery diarrhea—referred to as Zollinger‑Ellison‑associated diarrhea.

  • Who it affects: Primarily adults aged 30‑60, but cases have been reported in adolescents and the elderly.
  • Prevalence: Gastrinomas occur in about 1–3 per million people per year. Approximately 70‑80 % of patients with ZES develop diarrhea at some point during the disease course.1
  • Gender: Slight male predominance (≈55 % male).

Symptoms

Diarrhea in ZES is usually caused by acid‑induced damage to the intestinal mucosa, rapid transit, and malabsorption. It may appear alone or alongside the classic ZES triad of abdominal pain, peptic ulcer disease, and gastro‑esophageal reflux.

  • Watery, non‑bloody diarrhea: 3‑10 loose stools per day; may be nocturnal.
  • Steatorrhea (fatty stools): Greasy, foul‑smelling stool due to malabsorption of fat.
  • Abdominal cramping: Often worsens after meals when acid secretion spikes.
  • Upper‑abdominal pain: Burning or gnawing pain related to peptic ulcers.
  • Nausea / vomiting: May accompany pain or occur with ulcer complications.
  • Weight loss: Result of malabsorption and chronic fluid loss.
  • Electrolyte disturbances: Low potassium, magnesium, and bicarbonate can cause muscle weakness or arrhythmias.
  • Fatigue and weakness: Secondary to dehydration and electrolyte loss.
  • Recurrent ulcers: Ulcers that fail to heal despite standard therapy are a hallmark of ZES.

Causes and Risk Factors

Diarrhea in ZES is not a primary disease; it is a downstream effect of gastrin‑driven hyperacidity.

Primary cause

  • Gastrinoma: A neuroendocrine tumor that secretes gastrin autonomously, leading to >200 pg/mL fasting gastrin levels (normal < 100 pg/mL). The excess acid overwhelms the duodenal bicarbonate buffer, damaging the mucosa.

Risk factors for developing a gastrinoma and thus ZES‑related diarrhea

  • Multiple Endocrine Neoplasia type 1 (MEN‑1): Up to 25 % of ZES patients have MEN‑1, an inherited disorder that predisposes to pancreatic, parathyroid, and pituitary tumors.2
  • Family history of gastrinoma or MEN‑1.
  • Chronic Helicobacter pylori infection: May exacerbate acid output, though it is not a direct cause of gastrinoma.
  • Smoking: Increases risk of neuroendocrine tumors.
  • Age & gender: Middle‑aged men have a slightly higher incidence.

Diagnosis

Diagnosing Zollinger‑Ellison‑associated diarrhea requires confirming both the underlying gastrinoma and the resultant acid‑related intestinal changes.

Initial clinical assessment

  • Detailed history focusing on stool frequency, volume, timing (especially nocturnal), and accompanying ulcer symptoms.
  • Physical exam for dehydration, abdominal tenderness, and signs of malnutrition.

Laboratory tests

  • Fasting serum gastrin: Levels > 1000 pg/mL are highly suggestive of gastrinoma, especially when gastric pH < 2.3
  • Secretin stimulation test: An increase in gastrin > 120 pg/mL after IV secretin confirms Zollinger‑Ellison syndrome.
  • Stool studies: Fecal fat quantification and electrolytes help assess malabsorption and severity of diarrhea.
  • Electrolyte panel: Detect hypokalemia, hypomagnesemia, and metabolic alkalosis.

Imaging studies

  • Endoscopic ultrasound (EUS): High‑resolution detection of small pancreatic or duodenal lesions.
  • Multiphasic contrast‑enhanced CT or MRI: Localizes primary tumor and assesses for metastasis (liver is most common site).
  • Somatostatin receptor scintigraphy (Octreoscan) or ^68Ga‑DOTATATE PET/CT: Sensitive for neuroendocrine tumors.

Endoscopic evaluation

  • Upper GI endoscopy identifies multiple or refractory peptic ulcers, which are a diagnostic clue.
  • Biopsy of suspicious lesions helps rule out other causes (e.g., adenocarcinoma).

Treatment Options

Therapy targets three goals: (1) control gastric acid hypersecretion, (2) treat the gastrinoma, and (3) manage diarrhea and its nutritional consequences.

Acid‑suppression medications (first line)

  • High‑dose Proton Pump Inhibitors (PPIs): Omeprazole 80‑120 mg/day, esomeprazole 40‑80 mg/day, or pantoprazole 80‑120 mg/day. PPIs are >90 % effective at normalizing gastric pH and reducing diarrhea.4
  • Potassium‑competitive acid blockers (P‑CABs): Vonoprazan (available in some regions) offers rapid, sustained acid inhibition and may be useful in PPI‑resistant cases.

Somatostatin analogues

  • Octreotide or lanreotide: Inhibit gastrin release, reduce tumor growth, and can lessen diarrhea when PPIs are insufficient.
  • Typical dosage: Octreotide 100–300 µg subcutaneously every 8 hours or long‑acting repeatable (LAR) depot monthly.

Targeted systemic therapy

  • Everolimus: An mTOR inhibitor approved for advanced neuroendocrine tumors; may control tumor burden.
  • Sunitinib: Tyrosine‑kinase inhibitor used in metastatic disease.

Surgical management

  • Curative resection: Pancreaticoduodenectomy (Whipple), distal pancreatectomy, or enucleation of duodenal gastrinomas when localized and resectable. Surgery offers the best chance for long‑term remission.
  • Enucleation of metastases: May be considered for isolated liver lesions.

Lifestyle and supportive measures

  • Hydration: Oral rehydration solutions (ORSs) or IV fluids for severe losses.
  • Electrolyte replacement: Oral potassium chloride or magnesium supplements as needed.
  • Dietary modifications: Low‑fat, low‑fiber diet during acute diarrhea; gradual re‑introduction of fiber once symptoms improve.
  • Probiotics: Strains such as Lactobacillus rhamnosus GG may help restore gut microbiota, though evidence is modest.

Living with Zollinger‑Ellison‑Associated Diarrhea

Chronic diarrhea can significantly affect quality of life. Below are practical strategies to maintain daily function.

Medication adherence

  • Take PPIs 30‑60 minutes before breakfast (or as directed). Missing doses can precipitate breakthrough diarrhea.
  • Set alarms or use pill‑organizer apps to avoid gaps.

Nutrition

  • Eat small, frequent meals (5‑6 per day) to avoid large acid spikes.
  • Include easily digestible proteins (e.g., eggs, low‑fat poultry) and limit high‑fat foods that worsen steatorrhea.
  • Consider a medium‑chain triglyceride (MCT) oil supplement; MCTs are absorbed directly into the portal system and bypass the need for bile emulsification.
  • Stay hydrated with electrolyte‑rich fluids (e.g., sports drinks, ORS) rather than plain water.

Monitoring

  • Keep a symptom diary: record stool frequency, consistency (Bristol Stool Chart), timing, and any triggers.
  • Check weight weekly; a loss >5 % in a month warrants medical review.
  • Periodic labs every 3‑6 months for electrolytes, calcium, vitamin D, and gastrin levels.

Physical activity

  • Mild‑to‑moderate aerobic exercise (walking, swimming) is safe once dehydration is corrected.
  • Avoid high‑intensity workouts during active diarrhea episodes to prevent worsening electrolyte loss.

Psychosocial support

  • Join support groups (e.g., NET Patient Foundation) for emotional coping.
  • Consider counseling if anxiety or depression develop due to chronic symptoms.

Prevention

Because the root cause is a tumor, primary prevention is limited. However, the following steps can reduce complications and improve outcomes.

  • Early detection in high‑risk families: Annual fasting gastrin testing for MEN‑1 carriers.
  • Smoking cessation: Lowers risk for neuroendocrine tumors.
  • Regular medical follow‑up: Imaging every 6‑12 months for known gastrinomas to catch progression early.
  • Prompt treatment of ulcer disease: Reduces mucosal injury that can exacerbate diarrhea.

Complications

If left uncontrolled, Zollinger‑Ellison‑associated diarrhea can lead to serious health problems.

  • Severe dehydration and electrolyte imbalance: May cause cardiac arrhythmias, muscle paralysis, or seizures.
  • Malnutrition and weight loss: Chronic fat and protein malabsorption can lead to micronutrient deficiencies (e.g., vitamin B12, iron).
  • Peptic ulcer perforation or bleeding: Life‑threatening intra‑abdominal emergencies.
  • Metastatic progression of gastrinoma: Liver metastases occur in 60‑70 % of patients with delayed diagnosis.
  • Osteoporosis: Chronic acid excess can impair calcium absorption.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe abdominal pain with rigidity or guarding (possible ulcer perforation).
  • Profuse watery diarrhea (>10 stools/24 h) with signs of dehydration: dizziness, rapid heartbeat, dry mouth, or reduced urine output.
  • Persistent vomiting accompanied by inability to keep liquids down.
  • Chest pain, shortness of breath, or palpitations (possible electrolyte‑induced cardiac arrhythmia).
  • Black, tarry stools or vomiting blood (upper GI bleed).
  • Sudden confusion, seizures, or loss of consciousness.

These symptoms require immediate medical evaluation to prevent life‑threatening complications.


Sources:

  1. Mayo Clinic. Zollinger‑Ellison syndrome. Link. Accessed June 2026.
  2. CDC. Multiple endocrine neoplasia type 1 (MEN1). Link. Accessed June 2026.
  3. Yao JC et al. Management of gastrinomas and ZES. Gastroenterology. 2015;149(5):1263‑1273. PMCID: PMC4479990.
  4. Cleveland Clinic. Zollinger‑Ellison syndrome. Link. Accessed June 2026.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.